• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home / Markets

Muted debut: Glenmark Life Sciences lists at Rs 751.10, a premium of 4.32%

On the NSE, Glenmark Life Sciences opened at Rs 750, at a premium of 4.17% over its issue price of Rs 720 per share.

  • Money9
  • Last Updated : August 6, 2021, 10:51 IST
  • Follow
The Rs 1,513.60-crore initial public offer of the company got subscribed 44.17 times on the closing day of the subscription on July 29.
  • Follow

The API (active pharmaceutical ingredients) arm of Glenmark Pharmaceuticals, Glenmark Life Sciences made a muted listing on the stock exchanges today. Shares of pharma chemical company Glenmark Life Sciences opened at Rs 750 per share on the National Stock Exchange, implying a premium of 4.17% from the issue price of Rs 720 per share. On the BSE, the stock opened at Rs 751.10, at a premium of 4.32%.

The Rs 1,513.60-crore initial public offer of the company got subscribed 44.17 times on the closing day of the subscription on July 29. The issue received bids for 66,33,24,160 shares against 1,50,18,279 shares on offer, according to NSE data. Qualified Institutional Buyers (QIBs) portion received 36.97 times subscription, non-institutional investors 122.54 times and retail individual investors 14.63 times. The company had fixed a price band of Rs 695-720 per share.

The IPO comprised fresh issuance of equity shares of Rs 1,060 crore, and an offer for sale (OFS) of 63,00,000 shares totalling to Rs 453.60 crore by Glenmark Pharmaceuticals.

The API manufacturer will utilise its net proceeds for payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company pursuant to the Business Purchase Agreement dated October 9, 2018 (Rs 800 crore), and funding capital expenditure requirements (Rs 152.76 crore) and meet general corporate purposes.

Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Currently, it has 4 manufacturing facilities at Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State with an aggregate annual installed capacity of 725.8 KL as of December 31, 2020.

Published: August 6, 2021, 10:07 IST

Download Money9 App for the latest updates on Personal Finance.

  • Gleanmark Life Sciences IPO
  • Gleanmark Life Sciences Listing Price
  • Gleanmark Life Sciences Premium

Related

  • देश का विदेशी मुद्रा भंडार 4.47 अरब डॉलर घटकर 688.1 अरब डॉलर पर
  • मौद्रिक नीति पर निर्णय से पहले सेंसेक्स 308 अंक टूटा, निफ्टी भी नुकसान में
  • जी एंटरटेनमेंट के शेयरधारकों ने प्रवर्तक संस्थाओं से 2,237.44 करोड़ जुटाने के प्रस्ताव को किया खारिज
  • 15 जुलाई तक मक्का, धान की फसलों का बीमा कराएं किसान: हमीरपुर जिला अधिकारी
  • सेंसेक्स की शीर्ष 10 कंपनियों में से नौ का बाजार पूंजीकरण 2.34 लाख करोड़ रुपये बढ़ा
  • नेस्ले इंडिया के निदेशक मंडल के 1:1 बोनस शेयर जारी करने को दी मंजूरी दी

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close